Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study

Background: Oral propranolol reduces retinopathy of prematurity (ROP) progression, although not safely. Propranolol 0.1% eye micro-drops administered to newborns with stage 2 ROP are well-tolerated, but not sufficiently effective. Methods: A multi-center open-label trial was conducted to assess the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pediatr
Main Authors: Filippi, Luca, Cavallaro, Giacomo, Berti, Elettra, Padrini, Letizia, Araimo, Gabriella, Regiroli, Giulia, Raffaeli, Genny, Bozzetti, Valentina, Tagliabue, Paolo, Tomasini, Barbara, Mori, Annalisa, Buonocore, Giuseppe, Agosti, Massimo, Bossi, Angela, Chirico, Gaetano, Aversa, Salvatore, Fortunato, Pina, Osnaghi, Silvia, Cavallotti, Barbara, Suzani, Martina, Vanni, Maurizio, Borsari, Giulia, Donati, Simone, Nascimbeni, Giuseppe, Nardo, Daniel, Piermarocchi, Stefano, la Marca, Giancarlo, Forni, Giulia, Milani, Silvano, Cortinovis, Ivan, Calvani, Maura, Bagnoli, Paola, Dal Monte, Massimo, Calvani, Anna Maria, Pugi, Alessandra, Villamor, Eduardo, Donzelli, Gianpaolo, Mosca, Fabio
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Pediatrics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6514240/
https://ncbi.nlm.nih.gov/pubmed/31134171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fped.2019.00180
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados